Interparfums, Inc. (IPAR)
(Delayed Data from NSDQ)
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Zacks News
TreeHouse Foods (THS) Q4 Earnings Beat, Sales Decline Y/Y
by Zacks Equity Research
TreeHouse Foods' (THS) fourth-quarter fiscal 2023 results reflect soft sales and earnings due to supply-chain hurdles at one of the broth facilities.
International Flavors (IFF) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
International Flavors' (IFF) Q4 results are likely to reflect the impacts of lower volumes and escalating costs.
Service Corp (SCI) Hikes Dividend: What Else Should You Know?
by Zacks Equity Research
Service Corp (SCI) announces a dividend increase, showcasing its commitment to delivering value to its shareholders.
Medifast (MED) Q4 Earnings Coming Up: What Should You Know?
by Zacks Equity Research
Medifast's (MED) fourth-quarter results are likely to reflect the impacts of macroeconomic challenges like inflation, while key growth initiatives like innovation bode well.
Is Inter Parfums (IPAR) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Inter Parfums (IPAR) and Kerry Group PLC (KRYAY) have performed compared to their sector so far this year.
Dutch Bros (BROS) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Dutch Bros' (BROS) fourth-quarter 2023 top-line results are likely to reflect gains from strength in its underlying business and expansion initiatives.
Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2023 results reflect the persistence of macroeconomic challenges and hurdles related to business transformation, offset by growth in some regions.
Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 27.59% and 1.94%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Molson Coors (TAP) Q4 Earnings & Sales Beat on Brand Strength
by Zacks Equity Research
Molson Coors' (TAP) fourth-quarter 2023 results benefit from brand strength and impressive performances across both its business units.
General Mills' (GIS) HMM Strategy Aids Despite Troubled Pet Unit
by Zacks Equity Research
General Mills' (GIS) HMM strategy and innovations position it for growth despite challenges, particularly in the Pet segment.
Newell (NWL) Q4 Earnings Surpass Estimates, Sales Down Y/Y
by Zacks Equity Research
Newell's (NWL) fourth-quarter 2023 sales decline 9.1% year over year on lower core sales and impacts of category exits.
TreeHouse Foods (THS) Q4 Earnings Coming Up: What to Expect?
by Zacks Equity Research
TreeHouse Foods' (THS) fourth-quarter results are likely to reflect supply-chain disruptions and the impacts of the recent voluntary product recall. Gains from pricing have been an upside.
What You Need to Know Ahead of Kraft Heinz (KHC) Q4 Earnings
by Zacks Equity Research
Kraft Heinz's (KHC) fourth-quarter results are likely to reflect the adverse impact of inflationary headwinds. Also, rising SG&A costs are concerning.
Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2023 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations pose concerns.
Service Corporation (SCI) to Report Q4 Earnings: Factors to Note
by Zacks Equity Research
Service Corporation's (SCI) fourth-quarter 2023 results are likely to reflect softness in its Funeral business. Also, the company is not immune to an inflationary environment.
Hershey (HSY) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Hershey's (HSY) Q4 results reflect gains from pricing amid lower volumes. The company continues to focus on innovation and efficiency despite market challenges.
Coty (COTY) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of 25% and 3.42%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Hain Celestial (HAIN) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) posts mixed results in second-quarter fiscal 2024. The International segment's net sales grew 8.5% year over year in the quarter.
McCormick (MKC) Gains on Innovation & Pricing Amid Cost Woes
by Zacks Equity Research
McCormick's (MKC) strategic focus on pricing, innovation and efficiency underpins its industry leadership and growth despite facing inflation and volume challenges.
Energizer (ENR) Q1 Earnings & Sales Beat Estimates, Dip Y/Y
by Zacks Equity Research
Energizer's (ENR) fiscal first-quarter earnings beat estimates by a couple of cents. Amid challenges, the company is focusing on cost-saving measures and undertaking strategic endeavors.
Kellanova (K) Q4 Earnings Coming Up: Factors to Consider
by Zacks Equity Research
Kellanova's (K) fourth-quarter performance is likely to reflect the adverse impact of rising costs and supply-chain bottlenecks. Unfavorable foreign currency rates are a hurdle.
Flowers Foods' (FLO) Q4 Earnings Coming Up: What to Expect?
by Zacks Equity Research
Flowers Foods' (FLO) fourth-quarter results are likely to reflect gains from pricing and brand strength, while high selling, distribution and administrative expenses might have hurt profits.
Things to Consider Before Hain Celestial's (HAIN) Q2 Earnings
by Zacks Equity Research
Hain Celestial's (HAIN) second-quarter fiscal 2024 earnings are likely to reflect weakness in the North America segment. Focus on brand-building efforts is an upside.
COTY Unveils Partnership With Luxury Fashion Brand Marni
by Zacks Equity Research
COTY's collaboration with Marni, which will be launched in fiscal 2026, aims to bolster its luxury segment with innovative beauty products, reflecting its strategy for growth and market expansion.
Hershey's (HSY) Q4 Earnings Coming Up: What Should You Know?
by Zacks Equity Research
Hershey's (HSY) fourth-quarter results are likely to reflect gains from pricing and brand strength, while high selling, marketing and administrative expenses might have dented the bottom line.